A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials

por Cabarrou, Bastien, Leconte, Eve, Sfumato, Patrick, Boher, Jean-Marie, Filleron, Thomas
Publicado 2022

Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial

por Filleron, Thomas, Le Guellec, Sophie, Chevreau, Christine, Cabarrou, Bastien, Lesluyes, Tom, Lodin, Sabrina, Massoubre, Angélique, Mounier, Muriel, Poublanc, Muriel, Chibon, Frédéric, Valentin, Thibaud
Publicado 2020

Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience

por Lamy, Tina, Cabarrou, Bastien, Planchard, David, Quantin, Xavier, Schneider, Sophie, Bringuier, Michael, Besse, Benjamin, Girard, Nicolas, Chouaid, Christos, Filleron, Thomas, Simon, Gaëtane, Baldini, Capucine
Publicado 2021

Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS

por Syrykh, Charlotte, Gorez, Pauline, Péricart, Sarah, Grand, David, Escudié, Frédéric, Cabarrou, Bastien, Obéric, Lucie, Ysebaert, Loïc, Lamant, Laurence, Laurent, Camille, Evrard, Solène M., Brousset, Pierre
Publicado 2021

A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas

por Gilhodes, Julia, Meola, Adèle, Cabarrou, Bastien, Peyraga, Guillaume, Dehais, Caroline, Figarella-Branger, Dominique, Ducray, François, Maurage, Claude-Alain, Loussouarn, Delphine, Uro-Coste, Emmanuelle, Cohen-Jonathan Moyal, Elizabeth
Publicado 2023

Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes

por Glemarec, Gauthier, Lacaze, Jean-Louis, Cabarrou, Bastien, Aziza, Richard, Jouve, Eva, Zerdoud, Slimane, De Maio, Eleonora, Massabeau, Carole, Loo, Maxime, Esteyrie, Vincent, Ung, Mony, Dalenc, Florence, Izar, Francoise, Chira, Ciprian
Publicado 2022

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

por Bories, Pierre, Prade, Naïs, Lagarde, Stéphanie, Cabarrou, Bastien, Largeaud, Laetitia, Plenecassagnes, Julien, Luquet, Isabelle, De Mas, Véronique, Filleron, Thomas, Cassou, Manon, Sarry, Audrey, Fornecker, Luc-Matthieu, Simand, Célestine, Bertoli, Sarah, Recher, Christian, Delabesse, Eric
Publicado 2020

Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer

por Angeles, Martina Aida, Cabarrou, Bastien, Gil-Moreno, Antonio, Pérez-Benavente, Asunción, Spagnolo, Emanuela, Rychlik, Agnieszka, Martínez-Gómez, Carlos, Guyon, Frédéric, Zapardiel, Ignacio, Querleu, Denis, Illac, Claire, Migliorelli, Federico, Bétrian, Sarah, Ferron, Gwénaël, Hernández, Alicia, Martinez, Alejandra
Publicado 2021

Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients

por Al Saati, Ayman, Vande Perre, Pierre, Plenecassagnes, Julien, Gilhodes, Julia, Monselet, Nils, Cabarrou, Bastien, Lignon, Norbert, Filleron, Thomas, Telly, Dominique, Perello-Lestrade, Emilie, Feillel, Viviane, Staub, Anne, Martinez, Mathilde, Chipoulet, Edith, Collet, Gaëlle, Thomas, Fabienne, Gladieff, Laurence, Toulas, Christine
Publicado 2023

Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results

por Pouessel, Damien, Ken, Soléakhéna, Gouaze-Andersson, Valérie, Piram, Lucie, Mervoyer, Augustin, Larrieu-Ciron, Delphine, Cabarrou, Bastien, Lusque, Amélie, Robert, Marie, Frenel, Jean-Sebastien, Uro-Coste, Emmanuelle, Olivier, Pascale, Mounier, Muriel, Sabatini, Umberto, Sanchez, Eduardo Hugo, Zouitine, Mehdi, Berjaoui, Ahmad, Cohen-Jonathan Moyal, Elizabeth
Publicado 2023